Cargando…
Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination is a very effective method of preventing infection and is recommended for people having recovered from coronavirus disease 2019 (COVID‐19). In this novel case report, we describe two patients with post‐COVID‐19 pneumonia who ex...
Autores principales: | Bando, Tomohiro, Takei, Reoto, Mutoh, Yoshikazu, Sasano, Hajime, Yamano, Yasuhiko, Yokoyama, Toshiki, Matsuda, Toshiaki, Kataoka, Kensuke, Kimura, Tomoki, Kondoh, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251883/ https://www.ncbi.nlm.nih.gov/pubmed/35814194 http://dx.doi.org/10.1002/rcr2.995 |
Ejemplares similares
-
Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
por: Bando, Tomohiro, et al.
Publicado: (2022) -
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023) -
Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021) -
Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation
por: Oi, Hajime, et al.
Publicado: (2020) -
Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system
por: Mutoh, Yoshikazu, et al.
Publicado: (2022)